CompletedNCT05551689
FOCUS ADHD Mobile Health App for Adult ADHD Patients
Medication studyAges 18–45Brazil
Understand this study
Who was this study for?
Listed age limits: 18 years to 45 years.
- Listed locations
- Porto AlegreSee all locations and recruitment
Study information
Study start dateStarted: May 21, 2021
- Recruitment status
- Completed
- Enrollment listed in the registry
- 73
- Sponsor
- Hospital de Clinicas de Porto Alegre
- Sponsor type
- Hospital / academic medical center
- Study type
- Drug
- Intervention type
- DEVICE, Medication / drug
- Study phase
- Not clearly listed
- Locations
- Brazil
- Age range
- From 18 Years to 45 Years
- Official registry ID
- NCT05551689
- Official title
Show the full official title
Evaluation of the Effectiveness of the FOCUS ADHD Mobile Health Platform in the Monitoring of Adults With Attention-Deficit/ Hyperactivity Disorder (ADHD)
Recruitment & locations
CompletedPorto Alegre
Questions about this study
Who is behind this study?
The study sponsor is Hospital de Clinicas de Porto Alegre, a hospital or academic medical center.
Did this study involve medication?
Yes. The study involved medication, including Psychostimulant.
Who was this study for?
Listed age limits: 18 years to 45 years.
Want to find a study that may fit you better?
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.
Find a study that may fit meRelated studies
Aripiprazole Associated With Methylphenidate in Children and Adolescents With Bipolarity and ADHD
Aripiprazole in Children and Adolescents With Bipolarity and Attention Deficit Hyperactivity Disorder (ADHD)